PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
13-Oct-2020 BioNJ's Prestigious Speaker Roster for Eighth Annual C-Suite Summit BioNJ
13-Oct-2020 Secarna Pharmaceuticals and Denali Therapeutics enter into research and option agreement to develop novel antisense therapies in the field of neurodegenerative diseases Secarna Pharmaceuticals GmbH & Co. KG
13-Oct-2020 MorphoSys AG Successfully Places EUR 325 Million Convertible Bonds MorphoSys AG
13-Oct-2020 BioGX Announces FDA Emergency Use Authorization Submission of Extraction-Free Direct RT-PCR Test for COVID-19 BioGX
13-Oct-2020 Moleculin Announces Additional Positive Interim Results in Adult Glioblastoma Clinical Trial Moleculin Biotech, Inc.
13-Oct-2020 MedTech Integrates 2020: Live online – 15 October 2020 Sciad Newswire
13-Oct-2020 Novellus Therapeutics Exclusively Licenses Induced Mesenchymal Stem Cells (iMSCs) to NoveCite for COVID-19 Related Acute Respiratory Distress Syndrome (ARDS) and Other Acute Respiratory Conditions Novellus Therapeutics
13-Oct-2020 Novellus Therapeutics Exclusively Licenses Induced Mesenchymal Stem Cells (iMSCs) to NoveCite for COVID-19 Related Acute Respiratory Distress Syndrome (ARDS) and Other Acute Respiratory Conditions Novellus Therapeutics
13-Oct-2020 Moleculin Announces Additional Positive Interim Results in Adult Glioblastoma Clinical Trial Moleculin Biotech, Inc.
13-Oct-2020 ProductLife Group Acquires Axpharma in Response to Accelerating Global Demand for Pharmacovigilance Support ProductLife Group
13-Oct-2020 Prestige Biopharma Receives Positive EMA Opinion on Orphan Designation for PBP1510 for Treatment of Pancreatic Cancer B3C newswire
13-Oct-2020 Apogenix Advances Clinical Development of CD95L Inhibitor Asunercept in European COVID-19 Phase II Trial Apogenix AG
13-Oct-2020 F4 Pharma Announces Formation of Scientific Advisory Board B3C newswire
13-Oct-2020 Abivax secures EUR 15m non-dilutive financing from Kreos Capital ABIVAX
13-Oct-2020 Ad hoc: MorphoSys AG Launches an Offering of approx. EUR 325 Million Convertible Bonds MorphoSys AG
13-Oct-2020 NeuroRx and Relief announce topline efficacy data from patients treated with RLF-100(TM) (aviptadil) under the U.S. FDA Expanded Access Protocol authorization for respiratory failure related to critical COVID-19 Relief Therapeutics Holdings AG
13-Oct-2020 Gerresheimer AG: Gerresheimer on track for strong second half-year Gerresheimer AG
13-Oct-2020 Gerresheimer AG: Gerresheimer on track for strong second half-year Gerresheimer AG
13-Oct-2020 Gerresheimer AG: Gerresheimer on track for strong second half-year Gerresheimer AG
13-Oct-2020 Formycon Receives Funding for COVID-19 Drug Research from the Bavarian Research Foundation Formycon AG